Simulations Plus, Inc.SLP
| Aug 31, 2013 | Aug 31, 2014 | Aug 31, 2015 | Aug 31, 2016 | Aug 31, 2017 | Aug 31, 2018 | Aug 31, 2019 | Aug 31, 2020 | Aug 31, 2021 | Aug 31, 2022 | Aug 31, 2023 |
---|
Net income | 3 | 3 | 4 | 5 | 6 | 9 | 9 | 9 | 10 | 12 | 10 |
---|
Depreciation and amortization | 42,573 | 47,231 | 211,454 | 196,250 | 151,444 | 3 | 3 | 3 | 4 | 4 | 4 |
---|
Change in fair value of contingent consideration | - | - | - | - | 38,188 | 152,752 | 109,060 | 202,500 | 0 | 0 | 1 |
---|
Amortization of Debt Discount (Premium) | - | - | - | - | - | - | - | - | 2 | 2 | -1 |
---|
Stock-based compensation | - | 144,327 | 295,243 | 347,077 | 585,018 | 709,083 | 1 | 2 | 3 | 3 | 5 |
---|
Deferred income taxes | - | - | -55,919 | 23,241 | 178,374 | 2 | 299,096 | 377,759 | 1 | 0 | - |
---|
Deferred income taxes | 366,986 | 1 | - | - | - | - | - | - | - | - | -2 |
---|
Currency translation adjustments | - | - | - | - | - | - | - | 58,467 | 0 | 0 | -0 |
---|
Loss (gain) from disposal of assets | - | - | - | - | - | - | - | - | - | - | -0 |
---|
Impairment of other intangibles | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Currency translation adjustments | - | - | - | - | - | - | - | 58,467 | 0 | 0 | -0 |
---|
Accounts receivable | -643,771 | -247,456 | -1,048,969 | 1 | 876,231 | 1 | -487,970 | 2 | 2 | 4 | -4 |
---|
Prepaid income taxes | - | 446,786 | -748,359 | 555,486 | -93,043 | -149,850 | 452,517 | 12,380 | 0 | 0 | -1 |
---|
Prepaid expenses and other assets | -41,317 | -4,014 | 104,836 | 29,093 | -40,528 | 153,682 | 93,877 | 398,213 | 0 | -1 | 1 |
---|
Accounts payable | -31,498 | -15,464 | 19,443 | -101,296 | 99,337 | 110,713 | -147,529 | 220,584 | 0 | -0 | -0 |
---|
Other liabilities | - | - | - | - | - | - | - | - | - | -1 | 1 |
---|
Deferred revenue | -42,555 | -58,857 | 48,573 | 97,477 | -252,582 | 27,966 | -29,747 | -81,305 | 0 | 2 | 0 |
---|
Accrued income taxes | -662,427 | - | 43,602 | -43,602 | -153,713 | - | - | - | - | - | -0 |
---|
Deferred revenue | -42,555 | -58,857 | 48,573 | 97,477 | -252,582 | 27,966 | -29,747 | -81,305 | 0 | 2 | 0 |
---|
Net cash provided by operating activities | 3 | - | - | - | 7 | 9 | 12 | 11 | 19 | 18 | 22 |
---|
Purchases of property and equipment | 53,150 | 24,486 | 71,369 | 39,121 | 175,961 | 183,291 | 137,745 | 231,380 | 2 | 1 | 0 |
---|
Purchase of short-term investments | - | - | - | - | - | - | - | 67 | 122 | 101 | 95 |
---|
Proceeds from sale of short-term investments | - | - | - | - | - | - | - | - | 100 | 109 | - |
---|
Proceeds from maturities of short-term investments | - | - | - | - | - | - | - | - | - | - | 115 |
---|
Purchased intangibles | - | - | - | - | - | - | - | 9 | - | - | 1 |
---|
Cash received in acquisition | - | - | 190,184 | - | 2 | - | - | 4 | - | - | - |
---|
Acquisition of Immunetrics, net of cash acquired | - | - | - | - | - | - | - | - | - | - | 8 |
---|
Capitalized computer software development costs | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
---|
Net cash provided by (used in) investing activities | -1,181,738 | - | - | - | -4,355,220 | -2,328,720 | -1,955,741 | -75,505,710 | -27 | 4 | 7 |
---|
Payment of dividends | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 |
---|
Payments on contracts payable | - | - | - | - | - | - | - | 2 | 1 | 4 | - |
---|
Proceeds from Stock Options Exercised | 27,985 | 98,625 | 57,043 | 182,049 | 111,404 | 635,583 | 788,147 | 629,747 | 1 | 1 | 2 |
---|
Proceeds from follow-on public offering, net | - | - | - | - | - | - | - | 108 | - | - | - |
---|
Repurchase and retirement of common shares | - | - | - | - | - | - | - | - | - | - | 20 |
---|
Net cash used in financing activities | - | - | - | - | -4,337,085 | -3,773,485 | -7,647,881 | 102 | -5 | -8 | -23 |
---|
Net increase (decrease) in cash and cash equivalents | - | - | - | - | - | - | - | - | -12 | 15 | 6 |
---|
Income taxes paid | 2 | 692,562 | 961,907 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 |
---|
Stock issued for acquisition of Lixoft | - | - | - | - | - | - | - | 3 | 1 | 1 | - |
---|
Liabilities Assumed | - | - | - | - | 6 | - | - | 5 | - | - | 6 |
---|
Right of use assets capitalized | - | - | - | - | - | - | - | 1 | 1 | 1 | 0 |
---|